- Home
- PYPD vs SRFM Comparison
PYPD vs SRFM Comparison
Compare PYPD & SRFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PYPD
- SRFM
- Stock Information
- Founded
- PYPD 2008
- SRFM 2011
- Country
- PYPD Israel
- SRFM United States
- Employees
- PYPD N/A
- SRFM N/A
- Industry
- PYPD Medical/Dental Instruments
- SRFM Transportation Services
- Sector
- PYPD Health Care
- SRFM Consumer Discretionary
- Exchange
- PYPD Nasdaq
- SRFM Nasdaq
- Market Cap
- PYPD 36.0M
- SRFM 114.6M
- IPO Year
- PYPD 2020
- SRFM 2023
- Fundamental
- Price
- PYPD $3.40
- SRFM $8.79
- Analyst Decision
- PYPD Strong Buy
- SRFM Buy
- Analyst Count
- PYPD 5
- SRFM 4
- Target Price
- PYPD $11.40
- SRFM $5.56
- AVG Volume (30 Days)
- PYPD 214.9K
- SRFM 19.1M
- Earning Date
- PYPD 08-13-2025
- SRFM 08-13-2025
- Dividend Yield
- PYPD N/A
- SRFM N/A
- EPS Growth
- PYPD N/A
- SRFM N/A
- EPS
- PYPD N/A
- SRFM N/A
- Revenue
- PYPD N/A
- SRFM $112,307,000.00
- Revenue This Year
- PYPD N/A
- SRFM N/A
- Revenue Next Year
- PYPD N/A
- SRFM $54.32
- P/E Ratio
- PYPD N/A
- SRFM N/A
- Revenue Growth
- PYPD N/A
- SRFM 31.17
- 52 Week Low
- PYPD $2.30
- SRFM $0.90
- 52 Week High
- PYPD $4.42
- SRFM $9.91
- Technical
- Relative Strength Index (RSI)
- PYPD 51.00
- SRFM 84.42
- Support Level
- PYPD $3.34
- SRFM $6.25
- Resistance Level
- PYPD $3.53
- SRFM $8.00
- Average True Range (ATR)
- PYPD 0.15
- SRFM 1.38
- MACD
- PYPD -0.04
- SRFM 0.59
- Stochastic Oscillator
- PYPD 14.68
- SRFM 86.24
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
About SRFM Surf Air Mobility Inc.
Surf Air Mobility Inc provides a regional air mobility platform to connect communities sustainably. The company is an electric aviation and air travel company expanding the category of regional air travel and reinventing flying through electrification. The company is building a regional air mobility ecosystem to sustainably connect the world's communities. It generates revenue through air mobility services.